Cogent Biosciences Inc (COGT) — Financial Flexibility Index
Cogent Biosciences Inc (COGT) has a Financial Flexibility Index of -0.26x as of December 2025. Free cash flow of $-78.29 Million (operating CF $-79.11 Million minus capex $811.00K) represents 0% of total liabilities ($301.24 Million). Also explore Cogent Biosciences Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cogent Biosciences Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Cogent Biosciences Inc across 11 annual periods. Check COGT capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Cogent Biosciences Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Cogent Biosciences Inc. For the full company profile including market capitalisation, see COGT company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.87x | $-262.89 Million | $-264.44 Million | $301.24 Million | ▲ +69.8% |
| 2024 | -2.89x | $-207.22 Million | $-207.79 Million | $71.61 Million | ▼ -6.7% |
| 2023 | -2.71x | $-150.83 Million | $-153.62 Million | $55.63 Million | ▼ -9.3% |
| 2022 | -2.48x | $-111.78 Million | $-118.64 Million | $45.08 Million | ▲ +22.2% |
| 2021 | -3.19x | $-57.04 Million | $-58.76 Million | $17.91 Million | ▼ -45.7% |
| 2020 | -2.19x | $-35.53 Million | $-35.85 Million | $16.25 Million | ▲ +6.9% |
| 2019 | -2.35x | $-41.48 Million | $-41.51 Million | $17.66 Million | ▼ -88.9% |
| 2018 | -1.24x | $-31.94 Million | $-32.49 Million | $25.69 Million | ▼ -3.8% |
| 2017 | -1.20x | $-24.92 Million | $-25.84 Million | $20.81 Million | ▼ -80.9% |
| 2016 | -0.66x | $-15.33 Million | $-18.64 Million | $23.16 Million | ▼ -184.8% |
| 2015 | 0.78x | $19.71 Million | $17.72 Million | $25.25 Million | — |